- For Inventors
- Our Process
- Agreements and Forms
- Policies and Procedures
- Software and Open Source Licensing
- TDC Programs
- OSU NSF I-Corps Site Program
- IP Basics
- Ownership of Intellectual Property
- Grant Applications as Prior Art
- Other Resources
- Technologies for Licensing
- University Startups
- About TDC
- Publications and Reports
Material Transfer Agreement
A material transfer agreement (MTA) is a legal agreement between the provider of biological materials or chemical compounds and the receiving party. It protects intellectual property and/or patent rights, establishes legal guidelines for the distribution of the material, and protects you and your research from legal liability as the result of an accident.
A Request for Outgoing Biological Materials/Chemical Compounds questionnaire must be completed in conjunction with your college research office if you receive a request to send materials. The college research office will forward the signed questionnaire to the Technology Development Center (TDC) for processing. TDC will prepare a MTA and forward it along with the questionnaire to the Assistant Vice President for Research Compliance for final approval of the transfer.
A Request for Incoming Biological Materials/Chemical Compounds questionnaire must be completed in conjunction with your college research office if you are requesting material. The college research office will forward the signed questionnaire and a copy of the provider's MTA to TDC for processing. TDC will review the provider's MTA and make any necessary revisions. Once the MTA is finalized TDC will forward it along with the questionnaire to the Assistant Vice President for Research Compliance for final approval of the transfer.
If material is transferred or received from a university or other non-profit entity, IPM may be able to use the uniform biological material transfer agreement (UBMTA). The UBMTA is an agreement to facilitate transfers of biological material between institutions that have signed the master agreement jointly developed by representatives of the National Institutes of Health, Association of University Technology Managers (AUTM), and the Pharmaceutical Manufacturers Association. Individual transfers are covered by an implementing letter that: 1) identifies the material and the participating parties, and 2) indicates the transfer is being made under the provisions of the master agreement signed by both institutions. OSU is a signatory institution, and in most cases, honors this agreement. We recommend using the UBMTA whenever possible to expedite the transfer process.
The MTA must be signed by the OSU Associate Vice President for Technology Development and Director of the Technology Development Center, located at 1201 S. Innovation Way Drive, Suite 210, Stillwater, OK 74074, before the material is transferred or received by you from another party. Contact the Technology Development Center (744.5361; email@example.com ) for more information.